Open AccessInflammatory Response in SARS-CoV-2 Infection of Patients with Schizophrenia and Long-Term Antipsychotic Treatment
Author(s) -
Silvia Moga,
Andreea Teodorescu,
Petru Ifteni,
Claudia Gavriș,
Paula-Simina Petric
Publication year - 2021
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s325062
Subject(s) - medicine , schizophrenia (object oriented programming) , antipsychotic , covid-19 , term (time) , psychiatry , inflammatory response , virology , intensive care medicine , immunology , inflammation , disease , outbreak , physics , quantum mechanics , infectious disease (medical specialty)
Schizophrenia patients are a population at particular risk of poor outcomes in COVID-19 infection. They have multiple comorbidities that have been identified as risk factors for severe COVID-19: diabetes, hypertension, chronic obstructive respiratory disease, and end-stage renal disease.